Clinical Trial

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Name: JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer — clinical trial record (NCT07497074)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn if the therapy of JSKN033 plus chemotherapy with or with bevacizumab is safe to treat patients with advanced cervical cancer. It will also learn about the antitumor activity and pharmacokinetic/ pharmacodynamic profiles of this therapy.

Trial Details

NCT Number	NCT07497074
Lead Sponsor	Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Conditions	Cervical Cancer
Enrollment	78 participants
Start Date	2026-04
Primary Completion	2027-10 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-27